Abiopharma

Change in holdings of interested parties/officers

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Directors Interest - Mr Gurdip Singh S/O Boor Singh

Change - Announcement of Cessation: Cessation of Chief Operating Officer

General Announcement: CLARIFICATION IN RELATION TO INFORMATION SET OUT IN THE ANNOUNCEMENT DATED 12 JUNE 2026

Omdia: Global Smartphone Average Selling Price to Reach $565 in 2026 as Vendors Prioritize Value Over Volume

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus

AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection

Register of shareholders, changes and capital status – exercise of warrants to others (non-tradable)

Became an interested party - Bank Leumi Le-Israel Ltd. - amended report